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Abstract	
Curcumin	(Curcuma	longa) is	a	plant-based	polyphenol	known	to	have	several	medicinal	properties.	
Although	several	promising	effects	of	using	curcumin	in	clinical	trials	have	been	observed,	its	overall	
medicinal	qualities	are	still	limited	due	to	low	bioavailability.	In	order	to	increase	the	bioavailability,	we	
are	embedding	curcumin	within	Nano-Lipid	Particles	(both	curcumin	telodendrimer	discs	and	curcumin	
tNLPs).	
Telodendrimer	nanolipoprotein particles	(tNLPs)	are	discoidal	self-assemblies	containing	lipids	and	
apolipoproteins	which	can	be	used	as	a	vehicle	to	carry	proteins	and	other	small	molecules	to	the	cell.	
Telodendrimer	NLPs	have	been	used	to	increase	the	bioavailability	of	drugs,	and	provide	an	ideal	platform	
to	increase	curcumin	bioavailability.	The	generation	of	tNLPs	can	be	accomplished	using	several	methods;	
such	as	cell-free	assembly	and	in-vitro assembly.	
Curcumin	telodendrimer	discs	(curcumin	telo-discs)	are	a	nano-lipid	mixture	of	lipids,	curcumin,	and	
telodendrimer	that	acts	as	the	basis	for	the	curcumin	tNLP	reaction.	Using	the	curcumin	telo-disc	as	the	
starting	additive,	we	demonstrate	that	we	can	purify	properly	formed	curcumin	tNLPs	via	affinity	columns	
and	size-exclusion	chromatography	(SEC).	Here,	we	show	that	with	two	separate	methods:	a	cell-free	
expressed	method	and	in-vitro	assembly,	we	can	demonstrate	that	curcumin	can	be	successfully	
incorporated	and	purified	within	the	tNLP	particle	in	a	single	reaction	tube.
Introduction	
Nano-lipid	particles	act	as	a	platform	for	delivering	and	increasing	the	bioavailability	of	drugs	as	well	
as	other	small	molecules	into	the	cell.	Both	telodendrimer	discs	(telo-discs)	and	telodendrimer	
nanolipoprotein particles	(tNLPs)	have	the	potential	to	increase	cellular	uptake	of	the	“cargo”	with	which	
they	hold.	By	loading	the	curcumin	molecule	onto	telo-discs	and	tNLPs,	we	provide	a	novel	platform	to	
increase	curcumin	bioavailability.		Upon	curcumin	loading,	we	named	these	nano-lipid	particles	“curcumin	
telo-discs”	and	“curcumin	tNLPs”,	respectively.	
We	illustrate	three	main	methods	we	developed	to	form	curcumin	nano-lipid	particles.	Method	1	
outlines	the	curcumin	telo-disc	assembly.	In	brief,	lipid,	telodendrimer,	and	curcumin	are	mixed	and	
sonicated	in	an	Eppendorf	tube.	After	sonication,	curcumin	telo-discs	have	been	formed.	
Method	2	illustrates	the	cell-free	production	of	curcumin	tNLPs.	In	this	method,	we	combine	
curcumin,	lipids,	telodendrimer	and	ApoA1	plasmid	to	the	reaction	tube.	Upon	overnight	incubation	and	
shaking,	curcumin	tNLPs	form	spontaneously.
Method	3	demonstrates	an	in	vitro	production	of	curcumin	tNLPs.	Using	the	best-condition	from	the	
cell-free	assembly,	we	begin	this	procedure	with	curcumin	telo-disc	formation.	After	curcumin	telo-disc	
has	been	formed,	we	add	in	ApoA1	protein	and	incubate	overnight	to	form	spontaneous	curcumin	tNLPs.		
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We	used	cell-free	
approaches	for	making	
nanoparticles	(Methods	
1	&	2).	The	standard	
curve	created	uses	the	
absorption	of	curcumin	
to	determine	its	soluble	
concentration.	To	create	
the	standard	curve,	we	
had	to	make	two	fold	
dilutions	of	curcumin	in	
DMSO.	Our	pooled	
elutions containing	
soluble	nanoparticles	
with	the	highest	
intensity	of	yellow	
coloring	were	quantified	
according	to	the	
standard	curve.	
Importantly,	we	found	
that	the	highest	loading	
capacity	was	when	the	
curcumin	telo-disc	was	
mixed	prior	to	adding	
ApoA1	plasmid	during	
the	assembly	of	the	
nanoparticle	through	
cell-free	production.
Loading	Capacity	Equation:
mg	Apolipoprotein	A1
mg	Curcumin
y	=	10.681x	+	0.0028
R²	=	0.99969
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In-Vitro	curcumin	tNLPs	can	be	
characterized	by	SEC
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The	pictures	represent	the	
elutions from	affinity	purification	
using	column	chromatography	to	
purify	the	nanoparticles.	A)	
Illustrates	the	color	of	the	
elutions containing	curcumin	in	
visible	light,	which	show	a	yellow	
color	indicating	the	presence	of	
curcumin.	B)	Illustrates	the	color	
of	the	elutions containing	
curcumin	in	UV	light,	which	
indicates	the	solubility	of	the	
curcumin	associated	with	the	
nanoparticle.	
We	pooled	elutions that	have	
intense	yellow	coloring,	
indicating	increased	curcumin	
concentrations,	for	further	
analysis.		
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create	curcumin	loaded	nanoparticles
Findings	and	future	directions	
We	managed	to	create	curcumin	nano-lipid	particles	by	using	three	different	methods;	curcumin	telo-
disc,	cell-free	curcumin	tNLPs,	and	in-vitro	curcumin	tNLPs.	We	showed	through	both	affinity	purification	
and	size-exclusion	chromatography	(SEC)	that	the	homogenous	curcumin-tNLPs	form	with	both	cell-free	
and	in-vitro	methods.		
The	Next	Steps:	
1. Quantify	the	amount	of	curcumin	and	protein	that	is	in	each	tNLP.
2. Find	the	maximum	loading	capacity	of	the	curcumin-tNLPs.
3. Finally	take	the	tNLPs	and	test	on	cell	cultures	and	animal	models.	
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We	also	used	traditional	in-vitro	approaches	
for	making	nanoparticles	(Method	3).	For	this	
reaction	we	wanted	to	confirm	that	the	
curcumin	and	the	apolipoprotein	(ApoA1)	co-
elute	within	the	same	fractions	using	size	
exclusion	chromatography,	which	separates	
large	particles	from	small	particles.	The	
particles	contain	protein	that	can	be	measured	
at	280	nm.	In	addition,	we	can	obtain	a	
spectral	chromatograph	of	the	soluble	
curcumin	at	430	nm.	In	both	sets	of	graphs	we	
are	looking	to	make	sure	that	peaks	are	seen	
at	about	2.5	minutes,	which	is	where	the	
expected	size	range	is	for	properly	formed	
tNLPs.	Particles	that	elute	before	2.0	minutes	
are	considered	aggregates	or	void	volume.	
A.) The	first	two	graphs	represent	the	tNLPs	
that	were	made	by	Method	#3,	variation	#1.	Is	
a	variation	where	curcumin	telo-disc	were	
combined	with	ApoA1	protein	and	sonicated	
for	30	minutes	before	overnight	incubation.
B.)	The	last	two	graphs	represent	the	tNLPs	
that	were	made	by	Method	#3,variation	#2.	
Here,	the	curcumin	telo-disc	was	combined	
with	ApoA1	protein	and	sonicated	for	30	
minutes	before	overnight	incubation.	The	next	
morning,	more	curcumin	was	added.	
Method	#1:	Curcumin	Telo-Disc	
Method	#2:	Cell-Free	Curcumin	tNLPs
Method	#3:	In	Vitro	Curcumin	tNLPs
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There		are	two	variations	to	the	procedure	above:
1)	Sonicate	for	30	minutes	before	overnight	incubation.
2)	Sonicate	for	30	minutes	before	overnight	incubation,	and	add	more	curcumin	the	next	morning.
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